ISRCTN44960833已完成未知
D-cycloserine-supported exposure in patients with panic disorder
Charite - University Medicine Berlin (Charite - Universitatsmedizin Berlin) (Germany)0 个研究点目标入组 44 人开始时间: 2008年3月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Subject familiarised with experimental procedure and had given written informed consent according to AMG §40(1)3b
- •2. Diagnosis of panic disorder with agoraphobia, at least moderately ill
- •3. Age: 18-75 years
- •4. Sufficiently able to communicate with investigator, answer questions and fill in questionnaires
- •5. If pre-menopausal female: negative pregnancy test and safe contraception during study period
- •6. Reachability of patient for treatment and follow-up
- •7. Compliance of patient
排除标准
- •1. Known overreaction to D-cycloserine
- •2. Hospitalisation in a mental institution according to AMG §40(1)4
- •3. Other psychiatric illnesses like schizophrenia, substance abuse or dementia
- •4. Acute suicidal tendency
- •5. Epilepsy or other illness of the central nervous system (CNS) (e.g. brain tumour, encephalitis)
- •6. Severe medical illness like severe hypertension, severe cardiac insufficiency, condition after acute myocardial infarction, cardiac arrhythmia of severity index IV or V according to Lown grade, severe dysfunction of liver or kidney, diabetes mellitus requiring insulin treatment, disturbances of haematopoiesis
- •7. Pregnancy or breastfeeding
- •8. Changes of psychopharmacological treatment within the last eight weaks or discontinuation of psychopharmacological treatment within less than four weeks before beginning of the study
- •9. Recent interference with diurnal cycle
研究者
相似试验
进行中（未招募）
不适用
D-cycloserine augmented exposure therapy in patients with agoraphobiaEUCTR2011-001398-19-DECharité Universitätsmedizin Berlin
进行中（未招募）
1 期
D-CYCLOSERINE ENHANCEMENT OF EXPOSURE TREATMENT OF DENTALLY FEARFUL AND AVOIDANT CHILDREN. A PILOT STUDYAvoidance of dental care because of dental anxiety often result in reduced dental health and need for sedation or treatment in general anesthesia. Treatment of dental anxiety is time consuming and not given priority. D-cycloserine has shown to increase the effectiveness of the anxiety/ phobia treatment among adults, but needs to be tested among younger age groups. A medication that will enhance the effect of the anxiety treatment would be of great advantage for the fearful young patient.EUCTR2010-019712-20-NOniversity of Oslo, Institute of Clinical Dentistry
招募中
2 期
Efficacy of D-Cycloserine in combination with intensive exposure therapy in the treatment of obsessive compulsive disorder (OCD) in childreMental Health - Other mental health disordersPediatric Obsessive Compulsive DisorderACTRN12616000473460Dr Lara Farrell80
已完成
3 期
D-cycloserine (DCS) enhancement of exposure therapy in panic disorder with agoraphobia: a randomized controlled trial.panic disorder with agoraphobia/panic attacks with phobia in open spaces10002861NL-OMON34605niversiteit Utrecht60
进行中（未招募）
不适用
D-cycloserine (DCS) enhancement of exposure therapy in panic disorder with agoraphobia: a randomized controlled trial. - D-cycloserine enhancement of exposure therapypanic disorder with agoraphobiaMedDRA version: 12.1Level: LLTClassification code 10052794Term: Panic disorder with agoraphobiaEUCTR2010-021198-35-NLniversity Utrecht